‘Pharmaceutical/bio compliance issues and countermeasures’...Daeryun Medical/Pharmaceutical Group seminar held on the 7th

Listen to opinions and present solutions centered on the revised Pharmaceutical Affairs Act, including the CSO reporting system and disclosure of expenditure reports
March 7th, 2pm, Daeryun Yeouido headquarters conference room

As tensions are rising with recent strengthening of regulations on illegal rebates in the medical and pharmaceutical industries, a seminar is being held for pharmaceutical and bio companies.

Daeryun Medical Pharmaceutical Group, a law firm, announced on the 28th that it will hold a seminar on the theme of ‘Issues and practices of compliance in the pharmaceutical field - Focusing on the revision of the Pharmaceutical Affairs Act’ in the conference room of its headquarters in Yeouido, Seoul on March 7th at 2:00 PM.

This seminar was prepared to prepare for the pharmaceutical sales sales operator (CSO) reporting system that will be introduced from 2024 and the expenditure report disclosure system on details of economic benefits that will be implemented starting this month.

Daeryun plans to deal in depth with current issues and response plans that arise during the introduction of compliance, focusing on lawyers specializing in pharmaceuticals, biotechnology, healthcare, and fair trade.

This seminar will be held on a total of four topics. First, in the first session, attorney Choi Yun-jeong, a pharmaceutical expert with a pharmacist qualification, will give a presentation on the topic of ‘Pharmaceutical companies and CSOs’ expenditure report preparation and disclosure system.’ Attorney Choi Yoon-jeong plans to explain the CSO reporting system, how to prepare expenditure reports, and related issues, focusing on the revised Pharmaceutical Affairs Act.

In the second session, Attorney Kyejun Son, head of the Corporate Legal Group, will make a presentation. Attorney Gye-jun Son, a former secretary of the Fair Trade Commission, plans to introduce pharmaceutical rebate regulations under the Fair Trade Act and the Fair Trade Compliance Program (CP).

The third session will be chaired by advisor Choi Myeong-soon, who is considered an authority in the medical and pharmaceutical industries. Advisor Choi Myeong-soon, who has worked for about 30 years at the National Health Insurance Corporation and the Health Insurance Review and Assessment Service, plans to give a presentation on the practice of follow-up management of supply details related to pharmaceutical distribution, expenditure reports, and administrative disposition of drugs that disrupt the distribution order.

In the final session, tax accountant Lim Jeong-oh will give a presentation on the topic of ‘Tax issues that arise when rebates are discovered.’ Tax accountant Lim Jeong-oh, who has provided tax adjustment and advice to hospitals, clinics, manufacturing companies, etc., will analyze various cases and provide assistance in preparing response strategies based on this.

Anyone involved in the seminar, including those in charge of pharmaceuticals, biotechnology, and corporate legal affairs, can participate for free. Applications for participation can be made on the Daeryun website.

Kim Kook-il, CEO of Management, said, “This seminar was prepared to listen to the difficulties of pharmaceutical and bio companies regarding rebate regulations, such as the CSO reporting system and disclosure of expenditure reports, and to suggest practical solutions.” He added, “As this is an opportunity to share and communicate with current issues, we ask for your interest and participation.”

Meanwhile, Daeryun Medical Pharmaceutical Group successfully completed the first seminar on the theme of ‘Understanding Evergreening Patent Strategy’ in January 2025, and plans to hold seminars covering various fields in the future.

Reporter Son Dong-wook (twson@lawleader.co.kr)

[View full article]
Lawleader - ‘Pharmaceutical/Bio compliance issues and countermeasures’···Daeryun Medical/Pharmaceutical Group seminar held on the 7th (go)
Roishu - “Discussion of pharmaceutical and bio compliance issues and countermeasures”… Daeryun held seminar on the 7th (Go here)